458 related articles for article (PubMed ID: 28148598)
1. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
[TBL] [Abstract][Full Text] [Related]
2. Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection.
Parkes MD; Halloran PF; Hidalgo LG
Transplantation; 2017 Apr; 101(4):e102-e111. PubMed ID: 27906829
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
Cai Q; Moore SA; Hendricks AR; Torrealba JR
Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
[TBL] [Abstract][Full Text] [Related]
4. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
5. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.
Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M
Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781
[TBL] [Abstract][Full Text] [Related]
6. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
[TBL] [Abstract][Full Text] [Related]
7. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
8. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
9. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
Dos Santos DC; Campos EF; Saraiva Câmara NO; David DS; Malheiros DM
Transpl Int; 2016 Apr; 29(4):443-52. PubMed ID: 26615051
[TBL] [Abstract][Full Text] [Related]
10. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.
Gupta A; Broin PÓ; Bao Y; Pullman J; Kamal L; Ajaimy M; Lubetzky M; Colovai A; Schwartz D; de Boccardo G; Golden A; Akalin E
Kidney Int; 2016 Jan; 89(1):217-25. PubMed ID: 26422506
[TBL] [Abstract][Full Text] [Related]
12. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
[TBL] [Abstract][Full Text] [Related]
14. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
[TBL] [Abstract][Full Text] [Related]
15. Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies.
Hayde N; Broin PÓ; Bao Y; de Boccardo G; Lubetzky M; Ajaimy M; Pullman J; Colovai A; Golden A; Akalin E
Kidney Int; 2014 Sep; 86(3):600-9. PubMed ID: 24670411
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
[TBL] [Abstract][Full Text] [Related]
17. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
18. Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection.
Adam N; Coutance G; Viailly PJ; Drieux F; Ruminy P; Sater AA; Toquet C; Rouvier P; François A; Chenard MP; Epailly E; Guillemain R; Pattier S; Gay A; Varnous S; Taupin JL; Rabant M; Loupy A; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2020 Feb; 39(2):115-124. PubMed ID: 31822443
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
20. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
Husain AN; Mirza KM; Fedson SE
J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
